| |
CON
|
STZ
|
|---|
|
ECG parameters (n)
|
10
|
9
|
|
Heart rate (bpm)
|
349 ± 16
|
297 ± 8.9*
|
|
R –R (ms)
|
175 ± 8.2
|
203 ± 6.1*
|
|
P –wave (ms)
|
23 ± 1.5
|
23 ± 0.8
|
|
P-Q interval (ms)
|
49 ± 3.1
|
55 ± 2.8
|
|
QRS interval (ms)
|
16 ± 0.4
|
18 ± 0.7*
|
|
T- wave (ms)
|
49 ± 3.2
|
64 ± 2.6*
|
|
QT (ms)
|
64 ± 3.1
|
83 ± 2.5*
|
|
QTc (ms)
|
69 ± 3.2
|
82 ± 2.6*
|
|
P amplitude (mV)
|
0.09 ± 0.01
|
0.15 ± 0.01*
|
|
R amplitude (mV)
|
0.6 ± 0.05
|
0.9 ± 0.06*
|
|
T amplitude (mV)
|
0.14 ± 0.01
|
0.26 ± 0.03*
|
- Mean ± SEM, *p < 0.05 versus CON
- CON—controls, STZ—streptozotocin administered diabetic rats
